Oliver Karam, MD, PHD

NPI: 1174049282
Total Payments
$5,220
2021 Payments
$4,050
Companies
3
Transactions
12

Payment Breakdown by Category

Consulting$4,050 (77.6%)
Travel$741.14 (14.2%)
Food & Beverage$428.73 (8.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $4,050 1 77.6%
Travel and Lodging $741.14 4 14.2%
Food and Beverage $428.73 7 8.2%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim International GmbH $4,050 1 $0 (2021)
Merck Sharp & Dohme Corporation $1,046 10 $0 (2019)
BAXTER HEALTHCARE $123.73 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2021 $4,050 1 Boehringer Ingelheim International GmbH ($4,050)
2019 $1,170 11 Merck Sharp & Dohme Corporation ($1,046)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/06/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $4,050.00 General
Category: RESPIRATORY
09/19/2019 BAXTER HEALTHCARE No Related Product (Device) Food and Beverage In-kind items and services $123.73 General
Category: Surgical Care
09/12/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Travel and Lodging In-kind items and services $102.39 General
Category: INFECTIOUS DISEASE
09/12/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $55.00 General
Category: INFECTIOUS DISEASE
09/12/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $50.01 General
Category: INFECTIOUS DISEASE
09/12/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $34.99 General
Category: INFECTIOUS DISEASE
09/11/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Travel and Lodging In-kind items and services $410.15 General
Category: INFECTIOUS DISEASE
09/11/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Travel and Lodging In-kind items and services $192.10 General
Category: INFECTIOUS DISEASE
09/11/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $85.00 General
Category: INFECTIOUS DISEASE
09/11/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $55.00 General
Category: INFECTIOUS DISEASE
09/11/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Travel and Lodging Cash or cash equivalent $36.50 General
Category: INFECTIOUS DISEASE
09/11/2019 Merck Sharp & Dohme Corporation RECARBRIO (Drug) Food and Beverage In-kind items and services $25.00 General
Category: INFECTIOUS DISEASE

About Oliver Karam, MD, PHD

Oliver Karam, MD, PHD is a Pediatric Critical Care Medicine healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1174049282.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Oliver Karam, MD, PHD has received a total of $5,220 in payments from pharmaceutical and medical device companies, with $4,050 received in 2021. These payments were reported across 12 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($4,050).

Practice Information

  • Specialty Pediatric Critical Care Medicine
  • Other Specialties Pediatric Critical Care Medicine
  • Location New Haven, CT
  • Active Since 08/21/2017
  • Last Updated 06/07/2022
  • Taxonomy Code 2080P0203X
  • Entity Type Individual
  • NPI Number 1174049282

Products in Payments

  • OFEV (Drug) $4,050
  • RECARBRIO (Drug) $1,046
  • No Related Product (Device) $123.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Critical Care Medicine Doctors in New Haven